Phase 3 Allergy study

Study Details

A randomised, double-blind, controlled, parallel-group, multi-country study to investigate the effect of a partially hydrolysed infant formula with added synbiotics on the development of allergic manifestations in infants at high risk of developing allergy. (Maestro)

Protocol Number

N/A

Phase

III

Therapeutic Area

Others

Subject Types

With Medical Condition

Indication

Allergy

Principal Investigator

Dr Chan Poh Chong

Investigator Product / Device

N/A

Sponsor

N/A